Endoscopy 2020; 52(07): 583-588
DOI: 10.1055/a-1147-1348
Innovations and brief communications

Peroral endoscopic myotomy (POEM) for dysphagia and esophageal motor disorder after antireflux fundoplication

Jean-Michel Gonzalez
1   Service de gastroentérologie, Aix-Marseille Université, AP-HM, Hôpital Nord, Marseille, France
,
Laurent Monino
1   Service de gastroentérologie, Aix-Marseille Université, AP-HM, Hôpital Nord, Marseille, France
2   Department of Hepatogastroenterology, Université catholique de Louvain, Cliniques universitaires Saint-Luc, Brussels, Belgium
,
Philippe Ah-Soune
3   Service d’hépato-gastroentérologie, CHG Sainte Musse, Toulon, France
,
Véronique Vitton
1   Service de gastroentérologie, Aix-Marseille Université, AP-HM, Hôpital Nord, Marseille, France
,
Marc Barthet
1   Service de gastroentérologie, Aix-Marseille Université, AP-HM, Hôpital Nord, Marseille, France
› Author Affiliations

Abstract

Introduction Laparoscopic fundoplication is the treatment of severe and refractory gastroesophageal reflux disease (GERD). It induces dysphagia in 5 % – 10 % owing to a tight valve ± esophageal motility disorders (EMD), with challenging management. We assessed the first case series assessing peroral endoscopic myotomy (POEM) in such a situation.

Methods A retrospective case series including eight patients with severe dysphagia after laparoscopic fundoplication who were treated by POEM. They were assessed clinically by Eckardt and Mellow – Pinkas dysphagia scores, and by high resolution manometry (HRM). The procedure was a regular esophageal POEM, mainly posterior, including a myotomy of the wrap. The objectives were to evaluate the clinical efficacy, technical difficulties, and complications of this approach.

Results HRM showed aperistalsis in 6 /8 patients and raised lower esophageal sphincter (LES) pressure in 5 /8. The median preoperative Eckardt and dysphagia scores were 5 and 3.5, respectively. The procedure was completed in 7 /8 patients, with a clinical efficacy rate (normalization of both scores) of 75 % (6 /8). Although the submucosa seemed more fibrotic and vascularized, no severe complications occurred.

Conclusion POEM is a newly described therapeutic option to consider for managing dysphagia due to EMD after laparoscopic fundoplication.



Publication History

Received: 08 August 2019

Accepted: 10 March 2020

Article published online:
23 April 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Carlsson R, Dent J, Watts R. et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998; 10: 119-124
  • 2 Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut 2012; 61: 1340-1254
  • 3 Stefanidis D, Hope WW, Kohn GP. et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 2010; 24: 2647-2669
  • 4 Dallemagne B, Perretta S. Twenty years of laparoscopic fundoplication for GERD. World J Surg 2011; 35: 1428-1435
  • 5 Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013; 108: 308-328 ; quiz 329
  • 6 Mardani J, Lundell L, Engström C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg 2011; 253: 875-878
  • 7 Ross SB, Gal S, Teta AF. et al. Late results after laparoscopic fundoplication denote durable symptomatic relief of gastroesophageal reflux disease. Am J Surg 2013; 206: 47-51
  • 8 Engström C, Cai W, Irvine T. et al. Twenty years of experience with laparoscopic antireflux surgery. Br J Surg 2012; 99: 1415-1421
  • 9 Kahrilas PJ, Shaheen NJ, Vaezi MF. et al. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135: 1392-1413 , 1413.e1–e5
  • 10 Richter JE. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol 2013; 11: 465-471
  • 11 Hoshino M, Omura N, Yano F. et al. Impact of reflux esophagitis on the esophageal function before and after laparoscopic fundoplication. Esophagus 2018; 15: 224-230
  • 12 Mello MD, Shriver AR, Li Y. et al. Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease. Neurogastroenterol Motil 2016; 28: 292-298
  • 13 Lamb PJ, Myers JC, Jamieson GG. et al. Long-term outcomes of revisional surgery following laparoscopic fundoplication. Br J Surg 2009; 96: 391-397
  • 14 Hui JM, Hunt DR, Carle DJ. et al. Esophageal pneumatic dilation for postfundoplication dysphagia: safety, efficacy, and predictors of outcome. Am J Gastroenterol 2002; 97: 2986-2991
  • 15 Sunjaya D, Podboy A, Blackmon SH. et al. The effect of pneumatic dilation in management of postfundoplication dysphagia. Neurogastroenterol Motil 2017; 29: e13030
  • 16 Werner YB, Hakanson B, Martinek J. et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. NEJM 2019; 381: 2219-2229
  • 17 Ponds FA, Fockens P, Lei A. et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA 2019; 322: 134-144
  • 18 Bechara R, Onimaru M, Ikeda H. et al. Per-oral endoscopic myotomy, 1000 cases later: pearls, pitfalls, and practical considerations. Gastrointest Endosc 2016; 84: 330-338
  • 19 Barbieri LA, Hassan C, Rosati R. et al. Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia. United Eur Gastroenterol J 2015; 3: 325-334
  • 20 Inoue H, Sato H, Ikeda H. et al. Per-oral endoscopic myotomy: a series of 500 patients. J Am Coll Surg 2015; 221: 256-264
  • 21 Von Renteln D, Fuchs K-H, Fockens P. et al. Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology 2013; 145: 309-311.e1-e3
  • 22 Patel K, Abbassi-Ghadi N, Markar S. et al. Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and pooled analysis. Dis Esophagus 2016; 29: 807-819
  • 23 Kahrilas PJ, Bredenoord AJ, Fox M. et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27: 160-174
  • 24 Weijenborg PW, Savarino E, Kessing BF. et al. Normal values of esophageal motility after antireflux surgery: a study using high-resolution manometry. Neurogastroenterol Motil 2015; 27: 929-935
  • 25 Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Arch Intern Med 1985; 145: 1443-1446
  • 26 Bechara R, Ikeda H, Onimaru M. et al. Peroral endoscopic myotomy, 1000 cases later: pearls, pitfalls, and practical considerations. Gastrointest Endosc 2016; 84: 330-338
  • 27 Familiari P, Marchese M, Gigante G. et al. Peroral endoscopic myotomy for the treatment of achalasia in children. J Pediatr Gastroenterol Nutr 2013; 57: 794-797